Selective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studies.
about
Small-molecule AT2 receptor agonists.EMA401: an old antagonist of the AT2R for a new indication in neuropathic pain.Attenuation of the Infiltration of Angiotensin II Expressing CD3+ T-Cells and the Modulation of Nerve Growth Factor in Lumbar Dorsal Root Ganglia - A Possible Mechanism Underpinning Analgesia Produced by EMA300, An Angiotensin II Type 2 (AT2) ReceptPost-herpetic neuralgia - a review of current management and future directions.
P2860
Selective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Selective small molecule angio ...... clinical and clinical studies.
@en
type
label
Selective small molecule angio ...... clinical and clinical studies.
@en
prefLabel
Selective small molecule angio ...... clinical and clinical studies.
@en
P1433
P1476
Selective small molecule angio ...... clinical and clinical studies.
@en
P2093
Andrew S C Rice
Praveen Anand
P304
P356
10.1097/J.PAIN.0000000000000369
P407
P478
157 Suppl 1
P50
P577
2016-02-01T00:00:00Z